Acute bacterial prostatitis and abscess formation by unknown
RESEARCH ARTICLE Open Access
Acute bacterial prostatitis and abscess
formation
Dong Sup Lee1, Hyun-Sop Choe1, Hee Youn Kim1, Sun Wook Kim2, Sang Rak Bae3, Byung Il Yoon4
and Seung-Ju Lee1*
Abstract
Background: The purpose of this study was to identify risk factors for abscess formation in acute bacterial
prostatitis, and to compare treatment outcomes between abscess group and non-abscess group.
Methods: This is a multicenter, retrospective cohort study. All patients suspected of having an acute prostatic
infection underwent computed tomography or transrectal ultrasonography to discriminate acute prostatic
abscesses from acute prostatitis without abscess formation.
Results: A total of 31 prostate abscesses were reviewed among 142 patients with acute prostatitis. Univariate analysis
revealed that symptom duration, diabetes mellitus and voiding disturbance were predisposing factors for abscess
formation in acute prostatitis. However, diabetes mellitus was not related to prostate abscess in multivariate analysis.
Patients with abscesses <20 mm in size did not undergo surgery and were cured without any complications. In contrast,
patients with abscesses >20 mm who underwent transurethral resection had a shorter duration of antibiotic treatment
than did those who did not have surgery. Regardless of surgical treatment, both the length of hospital stay and antibiotic
treatment were longer in patients with prostatic abscesses than they were in those without abscesses. However, the
incidence of septic shock was not different between the two groups. A wide spectrum of microorganisms was
responsible for prostate abscesses. In contrast, Escherichia coli was the predominant organism responsible for
acute prostatitis without abscess.
Conclusion: Imaging studies should be considered when patients with acute prostatitis have delayed treatment
and signs of voiding disturbance. Early diagnosis is beneficial because prostatic abscesses require prolonged
treatment protocols, or even require surgical drainage. Surgical drainage procedures such as transurethral resection of the
prostate were not necessary in all patients with prostate abscesses. However, surgical intervention may have potential
merits that reduce the antibiotic exposure period and enhance voiding function in patients with prostatic abscess.
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Background
In general, abscesses form as a result of an inflammatory
process that arises from an infection. Therefore, it is
reasonable to assume that a prostate abscess develops
from a prostatic infection. However, to the best of our
knowledge, there have been no reports comparing acute
prostatitis with and without abscesses. Prostate abscess
is a rare condition. Only a few reports of its diagnosis
and treatment have been described over several decades
[1–4]. Several groups have suggested that indwelling
catheters, infravesical obstruction, instrumentation of
the lower urinary tract, diabetes mellitus (DM), liver
disease, and prostate biopsy are predisposing factors of
prostate abscess [5, 6]. These risk factors are reasonable,
but not yet supported by evidence. Patients with prostate
abscess must be watched closely, as they may experience
a high mortality rate if adequate and proper and timely
treatment does not occur [7]. However, compared to acute
prostatitis without abscess, outcomes of acute prostatitis
with abscess are unclear. Here, we present data from 142
acute bacterial prostatic infections and compare acute
bacterial prostatitis with and without abscess.
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This study is a retrospective, multicenter cohort study.
Chart review for each patient was done. Distinguishable in-
dividual information was thoroughly removed during data
collection. Data were gathered from four teaching hospitals
with 600–1000 beds in the capital region of Korea (Seoul
and Gyeonggi) using a web-based electronic system. Data
were shared among all of the involved institutions. A
central office managed all electronically recorded data.
Study population and design
Any male patient between 20 and 80 years old who pre-
sented between January 2012 and December 2014 was
eligible for the study. Patients were considered to have
acute prostate infection if they met the following criteria: (i)
one or more recent symptoms and signs such as voiding
disturbance, dysuria, urgency, frequency, perineal pain,
suprapubic pain or tenderness during digital rectal exam;
(ii) fever (temperature of tympanic membrane >37.8 °C,
[8]); and (iii) ≥5 white blood cells per high-power field in
the urine. All included patients had undergone computed
tomography (CT) or transrectal ultrasonography (TRUS).
Such imaging studies were used to determine the presence
or absence of an abscess. Successive cultures from the same
patient were excluded to avoid data duplication during the
treatment period. Patients with recurrent prostatitis were
also excluded because the condition could negatively or
positively influence susceptibility data. In order to access
voiding function, uroflowmetry or post-void residual urine
were checked in non-catheterized patients. Underlying
diseases were reviewed based on patient medical records.
The sensitive automatic MicroScan identification
system (Baxter Diagnostics, Inc., MicroScan, West
Sacramento, California, USA) was used to identify causative
bacteria. Minimal inhibitory concentrations (MICs) were
measured using the microbroth dilution method. The
following antibiotics were used to measure MICs:
ampicillin, amoxicillin/clavulanic acid, cephalothin,
cefoxitin, cefotaxime, ceftazidime, ciprofloxacin,
imipenem, piperacillin, piperacillin/tazobactam and
co-trimoxazole. A Sensitive/Intermediate/Resistant (SIR)
interpretation was used for simple description and easy
comparison of the data. We applied the standard Clinical
and Laboratory Standards Institute guidelines to establish
the MIC breakpoints.
Statistical analysis
Student’s t-tests or Mann–Whitney U tests were used to
compare continuous variables between the two groups.
The Chi-square test or Fisher’s exact test was also used
to perform univariate analysis of binominal variables.
The logistic regression test was used for multivariate
analysis. Each statistical method is also summarized
beneath the corresponding table.
Results
One hundred forty-two patients with acute prostatitis were
enrolled, 31 of these showed prostatic abscess. Of all of the
142 patients, 101 were admitted to the urology department
or department of infectious medicine from the emergency
department and 41 patients were admitted to the urology
department from outpatient clinics. 101 patients underwent
CT scans in the emergency department. Among these 101
patients, there were 22 prostatic abscesses without other as-
sociated abscesses, two prostatic abscesses with liver ab-
scesses, one prostatic abscess with a renal abscess, one
prostatic abscess with a buttock abscess and one renal ab-
scess without a prostatic abscess. 37 of 41 patients admitted
from outpatient clinics underwent TRUS when their fever
subsided. Based on this imaging study, three prostate ab-
scesses were diagnosed. The remaining four patients under-
went CT scanning because of persistent fever; this imaging
diagnosed two prostate abscesses without metastatic ab-
scess foci, and one liver abscess without a prostate abscess.
Therefore, a total of 31 prostate abscesses were diagnosed
and analyzed among a total of 142 acute bacterial prostatitis
cases. The baseline patient demographic characteristics are
summarized in Table 1.
In this study, the symptom duration and voiding dis-
turbance with low Qmax (<5 ml/sec) or high residual
urine (>100 ml) were associated with abscess formation
in acute bacterial prostatitis. Two of 17 prostate abscess
patients with voiding problems had urethral stricture.
The size of the prostate tended to be larger in acute
prostatitis patients with abscesses than in those without
abscesses, although not significantly. Over half of the
patients in the abscess group (51.6 %) had DM, while
28.8 % of non-abscess patients had DM (p = 0.03, OR =
2.633). Other underlying medical diseases were not associ-
ated with the presence of prostate abscess. Catheterization
also did not exert an influence on abscess formation in this
study. In multivariate analysis, symptom duration and
voiding disturbances were predisposing factors for
abscess formation in acute prostatitis (Table 2).
Twenty-six patients (83.8 %) with acute prostatitis with
abscesses eventually underwent suprapubic cystostomy. 14
patients with prostate abscess (45.2 %) had transurethral re-
section of prostate (TUR-P) during the treatment period
(Fig. 1). Among those 14 patients, one with a liver abscess
simultaneously underwent percutaneous drainage for liver
abscess. Only one patient among 15 patients who had pros-
tate abscess larger than 20 mm in maximal diameter, did
not have any procedures, and eventually died two days after
admission. 16 patients with abscesses less than 20 mm in
size were treated conservatively (Fig. 2a and b). Among the
30 survivors with prostatic abscesses, only one patient who
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Table 1 Demographic characteristics in 142 acute febrile prostatic infections
With abscess (n = 31) Without abscess (n = 111) Statistical results
Underlying factors
Age (years)† 62.23 ± 14.60 63.99 ± 14.27 0.546, 2.913, −7.524 ~ 3.994
BMI (Kg/m2)† 23.93 ± 4.04 24.05 ± 3.79 0.887, 0.827, −1.756 ~ 1.521
PSA (ng/ml)† 15.95 ± 11.46 20.76 ± 19.17 0.200, 3.730, −12.181 ~ 2.571
Prostate size (cc)† 47.73 ± 19.25 40.80 ± 17.53 0.063, 3.694, −0.377 ~ 14.242
Abscess size (mm) 22.03 ± 11.69 NA
<10 mm: 4; 10 ~ 20 mm: 12; 20 ~ 30 mm: 8; >30 mm: 7
Other abscess foci 4; 2 liver abscesses,
1 renal abscess,
1 buttock abscess
2; 1 liver abscess,
1 renal abscess
NA
Symptom duration† 7.81 ± 5.42 3.04 ± 2.57 <0.001, 0.691, 3.404 ~ 6.136
Underlying diseases
Diabetes mellitus‡ 16/31 32/111 0.030, 2.633, 1.165 ~ 5.951
Hypertension‡ 11/31 49/111 0.418, 0.696, 0.305 ~ 1.589
Heart disease‡ 4/31 23/104 0.316, 0.522, 0.166 ~ 1.644
Neurological deficit‡ 10/31 31/111 0.658, 1.229, 0.520 ~ 2.903
Chronic kidney disease* 4/31 16/111 1.000, 0.880, 0.271 ~ 2.851
Chronic lung disease* 2/31 11/111 0.734, 0.627, 0.131 ~ 2.991
Liver cirrhosis* 7/31 15/111 0.261, 1.867, 0.685 ~ 5.087







1.000, 1.082, 0.279 ~ 4.201
0.176, 2.866, 0.606 ~ 13.553
NA
NA
Long term catheterization* 2/31 12/111 0.735, 0.569, 0.120 ~ 2.689
Recent catheterization* 5/31 8/111 0.158, 2.476, 0.748 ~ 8.198
Voiding disturbance
(Qmax < 5 or PVR > 100)‡
15/31 15/111 <0.001, 6.000, 2.464 ~ 14.612
Treatment outcomes
Septic shock* 3/31 3/111 0.118, 3.857, 0.738 ~ 20.152
Death 1/31 1/111 0.390, 3.667, 0.223 ~ 60.360
Recurrence 1/31 3/111 1.000, 1.189, 0.119 ~ 11.848
Treatment duration† 40.96 ± 10.61 26.98 ± 9.43 <0.001, 2.111, 9.802 ~ 18.158
With TUR-P (n = 13)a 32.31 ± 9.34 0.001††
Without TUR-P (n = 13)b 40.85 ± 7.94
Admission duration† 12.38 ± 6.59 6.69 ± 2.92 <0.001, 1.321, 2.978 ~ 8.403
With TUR-P (n = 13)a 10.23 ± 2.55 0.650††
Without TUR-P (n = 13)b 11.08 ± 9.32
Follow-up duration† 216.0 ± 69.92 202.11 ± 59.01 0.302, 13.391, −12.602 ~ 40.378
†: These continuous values are expressed as means ± standard deviations and student t-tests were performed (statistical data include p-values, standard errors and
95 % confidence intervals, respectively)
‡,*: Statistical evaluation for the nominal parameters was performed using the Chi-squared test‡ or Fisher’s exact test* (statistical data include p-values, odds ratios
and 95 % confidence intervals, respectively.)
††: p-values between ‘a’ and ‘b’ were evaluated using the Mann–Whitney U test. Note that all cases (n = 13) treated by TUR-P had abscesses >20 mm in size
Among the 142 cases, 6 cases with metastatic abscesses (1 patient underwent TUR-P) and 2 fatal cases were excluded when comparing the treatment duration,
admission duration and follow-up duration
Abbreviations: BMI body mass index; PSA prostate specific antigen; Qmax (ml/sec) maximum urinary flow rate; PVR (ml) post-void residual; TUR-P transurethral
resection of prostate
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had been treated conservatively developed a recurrence
within 3 months. This patient eventually underwent trans-
urethral resection of prostate.
Six patients had additional abscess at distant sites.
Among the three cases of liver abscesses, two resulted
from K. pneumoniae infection, while the causative organ-
ism was not identified from the third. Most cases of acute
prostatitis without abscess resulted from infections with E.
coli. In contrast, various organisms were detected in cases
of acute prostatitis with abscess (Table 3). S. aureus was
significantly related to abscess formation (p = 0.03, OR =
12.222 by Fisher exact test). Squamous cell cancer was
identified in one case of acute prostatitis with abscess.
In general, the treatment period with antibiotics was lon-
ger in cases of prostate abscess than in those without ab-
scess, regardless of the surgical intervention. It is promising
that patients who underwent TUR-P required shorter anti-
biotic treatment than did patients treated conservatively,
despite the fact that the surgery group had larger prostate
abscesses than did the non-surgery group (Table 1). There
was no difference between prostate abscess and acute
prostatitis without abscess with regard to the incidence of
septic shock.
It was difficult to compare the susceptibility of E. coli, K.
pneumoniae and P. aeruginosa between the two groups
because of the small numbers of each respective isolate in
abscess group. Bacteria were detected in 120 of the 142
urinary specimens. Among these, E. coli was isolated in 78
specimens (65.0 %), and K. pneumoniae in 14 cases
(11.7 %). Therefore, E. coli and K. pneumoniae consisted of
76.7 % of acute prostatitis cases in this study. Antimicrobial
susceptibilities (%) of the 78 E. coli cases to cefoxitin (sec-
ond generation cephalosporins; cefamycins), cefotaxime
(third-generation cephalosporins) and ciprofloxacin (fluoro-
quinolones) were 75/78 (96.2), 64/78 (82.1) and 63/78
(80.8), respectively. Those of the 14K. pneumoniae cases to
cefoxitin, cefotaxime and ciprofloxacin were 14/14 (100.0),
14/14 (100.0) and 13/14 (92.9), respectively. Antimicrobial
susceptibility results in detail were presented in Table 4.
The susceptibilities of P. aeruginosa infection to third
generation cephalosporins and to fluoroquinolones
were lower than 80 % in both abscess and non-abscess
group. P. aeruginosa infection was related to previous
urological procedures (by Fisher exact test, p = 0.002,
OR = 13.889, 2.971 < 95 % CI < 64.927).
Discussion
One previous report described that approximately 6 % of
prostatic abscesses develop in patients during the follow-up
period after acute prostatitis [9]. However, prostatic abscess
are often found in patients who do not improve with initial
antibiotic therapy [6, 10]. Therefore, without routine
Table 2 Multivariate analysis of risk factors for abscess formation
in acute bacterial prostatitis
p-value OR 95 % CI
Voiding disturbance 0.041 2.749 1.551 ~ 12.333
Diabetes mellitus 0.153 2.064 0.764 ~ 5.575
Symptom duration <0.001 1.343 1.166-1.548
Statistical analysis was performed using logistic regression test
Fig. 1 Abscess drainage with transurethral resection of the prostate
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imaging study, a prostate abscess present initially may
be missed rather than developing from acute prostatitis
during the follow-up period. In our 111 cases of con-
firmed acute prostatitis without abscess, abscess forma-
tion was not identified during the treatment period.
Routine imaging studies such as CT or TRUS should be
considered in cases of acute prostatitis for this reason,
especially in patients with long-term symptom duration
and voiding disturbances. Such imaging will allow physi-
cians to anticipate a treatment method for an abscess, since
these abscesses may require drainage [3, 7]. Ludwig
et al. found that fluctuation during the digital rectal
Fig. 2 Medical treatment of prostate abscess. a: Before treatment (at diagnosis): an approximately 20-mm-sized abscess was identified in the left
lobe of the prostate gland, b: After treatment (follow-up at 4 weeks): a cystostomy catheter was inserted into the urinary bladder. The previous
abscess pocket was disappeared
Table 3 Microorganisms isolated from 142 urinary specimens
With Abscess n (%) Notes Without abscess n (%) Notes
E. coli 7 (26.9) 1 renal abscess 71 (74.7) 1 renal abscess, 1 death
K. pneumoniae 6 (23.1) 1 liver abscess 8 (8.4) 1 liver abscess
P. aeruginosa 4 (15.4) 4 (4.2)
P. mirabilis 1 (3.8) 1 (1.1)
K. oxytoca 1 (3.8) 1 (1.1)
Enterobacter aerogens 1 (3.8) 1 Death 2 (2.1)
Enterobacter clocae 0 (0.0) 1 (1.1)
Morganella morganii 1 (3.8) 1 (1.1)
Serratia marcescens 0 (0.0) 1 (1.1)
Citrobacter freudii 0 (0.0) 1 (1.1)
S. aureus 3 (11.5) 1 buttock abscess,
1 squamous cell carcinoma
1 (1.1)
E. faecalis 1 (3.8) 1 (1.1)
E. faecium 0 (0.0) 1 (1.1) 1 Death
Other GPC 1 (3.8) 1 (1.1)
Positive culture 26 95
Negative culture 5 1 Liver abscess 16
The percentage of each microorganism against positive culture is presented in parentheses
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exam was present in 83.3 % of prostate abscesses.
The group agreed that additional imaging is necessary
to avoid missing a diagnosis of prostate abscess [2].
DM was a predisposing factor for abscess formation in
univariate analysis. Studies of prostate abscesses commonly
emphasize that DM is the most important predisposing
Table 4 Antimicrobial susceptibility of E. coli, K. pneumoniae and P. aeruginosa infections
With abscess Without abscess
E. coli (n (%)) K. pneumoniae (n (%)) P. aeruginosa (n (%)) E. coli (n (%)) K. pneumoniae (n (%)) P. aeruginosa (n (%))
Amikacin S 7/7 (100.0) S 6/6 (100.0) S 3/4 (75.0) S 71/71 (100.0) S 8/8 (100.0) S 4/4 (100.0)
I 0/7 I 0/6 I 0/4 I 0/71 I 0/8 I 0/4
R 0/7 R 0/6 R ¼ R 0/71 R 0/8 R 0/4
Amoxicillin S 4/7 (57.1) S 0/6 (0.0) NA S 31/71 (43.7) S 0/8 (0.0) NA
I 0/7 I 0/6 I 0/71 I 0/8
R3/7 R 6/6 R 40/71 R 8/8
Amoxicillin/clavulanic acid S 5/7 (71.4) S 6/6 (100.0) NA S 48/71 (67.6) S 8/8 (100.0) NA
I 2/7 I 0/6 I 17/71 I 0/8
R 0/7 R 0/6 R 6/71 R 0/8
Aztreonam S 5/7 (71.4) S 6/6 (100.0) S 1/4 (25.0) S 65/71 (91.5) S 8/8 (100.0) S 2/4 (50.0)
I 0/7 I 0/6 I 1/4 I 0/74 I 0/8 I 1/4
R 2/7 R 0/6 R 2/4 R 6/74 R 0/8 R 1/4
Cefazolin S 5/7 (71.4) S 6/6 (100.0) NA S 54/71 (76.1) S 8/8 (100.0) NA
I 0/7 I 0/6 I 0/71 I 0/8
R 2/7 R 0/6 R 17/71 R 0/8
Cefepime S 5/7 (71.4) S 6/6 (100.0) S 3/4 (75.0) S 67/71 (94.4) S 8/8 (100.0) S 3/4 (75.0)
I 0/7 I 0/6 I 0/4 I 0/71 I 0/8 I 1/4
R 2/7 R 0/6 R ¼ R 4/71 R 0/8 R 0/4
Cefotaxime S 5/7 (71.4) S 6/6 (100.0) S 0/4 (0.0) S 59/71 (83.1) S 8/8 (100.0) S 0/4 (0.0)
I 0/7 I 0/6 I 0/4 I 0/71 I 0/8 I 0/4
R 2/7 R 0/6 R 4/4 R 12/71 R 0/8 R 4/4
Cefoxitin S 7/7 (100.0) S 6/6 (100.0) NA S 68/71 (95.8) S 8/8 (100.0) NA
I 0/0 I 0/6 I 2/71 I 0/8
R 0/0 R 0/6 R 1/71 R 0/8
Ceftazidime S 5/7 (71.4) S 6/6 (100.0) S 3/4 (75.0) S 68/71 (95.8) S 8/8 (100.0) S 4/4 (100.0)
I 0/7 I 0/6 I 0/4 I 0/74 I 0/8 I 0/4
R 2/7 R 0/6 R 1/4 R 3/71 R 0/8 R 0/4
Ciprofloxacin S 5/7 (71.4) S 6/6 (100.0) S 3/4 (75.0) S 58/71 (81.7) S 7/8 (87.5) S 3/4 (75.0)
I 0/7 I 0/6 I 0/4 I 0/71 I 0/8 I 0/4
R 2/7 R 0/6 R 1/4 R 13/71 R 1/8 R 1/4
Imipenem S 7/7 (100.0) S 6/6 (100.0) S 4/4 (100.0) S 71/71 (100.0) S 8/8 (100.0) S 4/4 (100.0)
I 0/0 I 0/6 I 0/4 I 0/71 I 0/8 I 0/4
R 0/0 R 0/6 R 0/4 R 0/71 R 0/8 R 0/4
Piperacillin/tazobactam S 7/7 (100.0) S 6/6 (100.0) S 2/4 (50.0) S 68/71 (95.8) S 7/8 (87.5) S 4/4 (100.0)
I 0/0 I 0/6 I 1/4 I 1/71 I 1/8 I 0/4
R 0/0 R 0/6 R 1/4 R 2/71 R 0/8 R 0/4
Cotrimoxazole S 5/7 (71.4) S 6/6 (100.0) S 0/4 (0.0) S 56/71 (78.9) S 6/8 (75.0) S 0/4 (0.0)
I 0/7 I 0/6 I 0/4 I 0/71 I 0/8 I 0/4
R 2/7 R 0/6 R 4/4 R 15/71 R 2/8 R 4/4
Susceptible categories (S/I/R: Sensitive/Intermediate/Resistant)
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medical condition [2, 3, 11]. However, diabetes by itself was
not a risk factor for prostate abscess in multivariate
analysis in the present study. DM is undoubtedly a ser-
ious condition that increases the risk of infection with
uro-pathogens [12, 13]. However, its role in the devel-
opment of prostatic abscess remains unclear and re-
quires further investigation. Voiding disturbance was a
significant risk factor for prostate abscess in the present
study. Therefore, physicians should monitor voiding status
in patients with acute prostatitis. In doing so, a physician
can decide whether or not to perform a urinary diversion,
such as suprapubic cystostomy, or to conduct imaging for
the early diagnosis of a prostate abscess.
Abscess drainage with transurethral resection of prostate
(TUR-P) was done in 45.2 % (14/31) of patients with pros-
tatic abscess. The other 55.8 % of patients with abscesses
only required medical treatment. We excluded confounding
factors including one patient death, and 4 patients with
other abscess foci when comparing the TUR-P group and
medical treatment group in 31 abscesses. With regard to
the length of hospital stay, it seems that medical treatment
was non-inferior to surgical procedures in the treatment of
prostatic abscesses. If we did not perform TUR-P in patient
with prostate abscess over 20 mm, hospital stay might be
longer in abscess patients. The duration of antibiotic treat-
ment was longer in the medical treatment group (Table 1)
than it was in the surgical group despite the cases treated
with TUR-P had larger size of abscess pockets than the
medical cases. Because TUR-P group and medical treat-
ment group have different sizes of prostate abscess, and
relevant cases in prostate abscess (n = 26) were small for
comparison between TUR-P (n = 13) and medical treat-
ment (n = 13), comparing treatment outcomes in 26 pros-
tate abscesses may have potentially less clinically significant
in the present study. However, considering there are wide
concerns of antibiotic resistance in the community, minim-
izing the duration of exposure to antibiotics is an important
issue. Furthermore, voiding disturbances were reflected in a
large proportion of patients with prostate abscesses
according to the present study. So, patients who under-
went TUR-P might have an advantage. Therefore, TUR-P
should be recommended to patients with prostate
abscesses, although surgical procedures are not ne-
cessary for relatively small abscesses.
Regardless of the surgical procedure, the presence of a
prostatic abscess did not increase the risk of septic shock
during treatment. In our experience, patients with prostate
abscesses require long-term antibiotic treatment and
potentially surgery depending on abscess size. However,
abscess formation may not exert an influence on the prog-
nosis, such as septic shock or death, under the assumption
that they were treated appropriately.
The vast majority of acute prostatitis were infected by
gram negative bacteria. Regardless of the presence of an
abscess, the selection of empirical antibiotics with cefox-
itin, cefotaxime or ciprofloxacin would be appropriate in
patients with acute prostatitis who have not undergone
urological procedure (s) in Korea. Nevertheless, clini-
cians should be ready to adjust the antibiotic regimen
according to susceptibility data, especially in the case of
prostate abscess. This is because unexpected microor-
ganisms are more likely to be isolated in acute prostatitis
with abscess than in those without abscess.
This study has limitations. It is a retrospective, multi-
centre chart review in design which has potential biases
associated with it, however designing a randomised con-
trol trial comparing treatment outcome in 2 groups of
equally matched patients with prostatic abscess is not
feasible given the rarity, severity of the disease and het-
erogeneity of management for this condition throughout
the urological community.
Conclusions
Ulleryd et al. concluded that [14] routine radiological
exams are dispensable in men with febrile urinary tract
infection. However, it would be wise to perform imaging
studies in patients who are suspected to have acute pros-
tatitis when their symptom duration is relatively long, or
any evidence of voiding disturbance. Acute prostatitis
with abscess requires long-term antibiotic treatment,
and sometimes even surgical drainage. Surgical proce-
dures such as TUR-P in patients with prostatic abscesses
are advantageous because they reduce the period of anti-
biotic treatment and may improve voiding symptoms. A
wide range of microorganisms may be detected in prosta-
titis with abscess. Therefore, physicians should perform
urine culture prior to administering empirical antibiotics.
These cultures should be repeated, if possible, during treat-
ment. With appropriate treatment, the prognosis of acute
prostatitis with and without abscess would not differ.
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